Steve Jolley is a subject matter expert in all areas of global safety compliance and signal detection, and is a frequent speaker at leading industry events.

Steve has 35 years’ experience in drug safety & pharmacovigilance and has worked with over 250 clients in North America, Europe, Japan, India, China, the Middle East and Africa. He holds degrees in mathematics and computer science from Cambridge University, England. He is an Adjunct Professor at Rutgers University and teaches part of their Master's degree in Drug Safety and Pharmacovigilance.

Steve is a featured speaker with FDA, EMA and MHRA at conferences and webinars on auditing, signaling and data mining. He is a member of DIA’s training faculty and is an instructor for DIA’s Clinical Safety and Pharmacovigilance Certificate Program. In 2010 Steve was elected as chairman of the DIA’s Clinical Safety and Pharmacovigilance steering committee for North America.

Steve began his career in the pharmaceutical industry in 1985 when he founded DLB Systems, a supplier of computer systems for clinical trials and adverse event reporting to many of the leading life science companies worldwide. DLB was acquired by eResearch Technologies in 1997; since then Steve has worked as an independent consultant.

1. Introduction to Drug Safety- Pharmacovigilance
2. Current Issues with the Medicine Supply Chain